The FDA has approved Epigenomics’ Epi proColon, making it the first and only FDA-approved blood-based colorectal cancer screening test.
The FDA’s Gastrointestinal Drugs Advisory Committee voted unanimously to recommend accelerated approval of Intercept Pharmaceuticals’ Ocaliva.
LifeBond received the CE Mark for its LifeSeal Surgical Sealant.
NanoAntibiotics acquired LAT Pharma, early-stage biotechnology company developing medicines to treat life-threatening complications of liver cirrhosis.
Bank of Montreal Can increased its stake in EndoChoice by 25.5 percent.
Boston Scientific’s SpyGlass DS Direct Visualization System was acquired by the Digestive Disease Centre of UCT Private Academic Hospital in Cape Town, South Africa.
Gilead Sciences presented data in a conference supporting the development of three investigational agents for the treatment of nonalcoholic steatohepatitis and primary sclerosing cholangitis.
More articles on GI/endoscopy:
4 GI devices receive FDA 510(k) clearance in March
Six steps to reduce taxes on investments
Bank of Montreal Can increases position in EndoChoice by 25.5%: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.